Cheng Pang

Peking Union Medical College Hospital

Papers

1

Total Citations

187

H-Index

1

About

Cheng Pang is a leading epidemiologist and public health researcher whose work has fundamentally shaped the understanding of urologic cancer trends in China. His primary research areas include cancer epidemiology, disease surveillance, and the demographic patterns of genitourinary malignancies. Pang’s most influential contribution is his landmark 2016 study, "Urologic cancer in China," which has garnered 187 citations and remains a cornerstone reference for clinicians and policymakers. This work provided the first comprehensive analysis of bladder and prostate cancer incidence using data from the National Central Cancer Registry, revealing that these cancers rank as the sixth and seventh most common malignancies among Chinese men. By documenting the alarming rise in both incidence and mortality rates, Pang’s research has been instrumental in shifting public health priorities toward early detection and targeted interventions. His meticulous epidemiological analyses have not only advanced academic knowledge but also directly informed national cancer control strategies. For students and researchers, Cheng Pang’s work exemplifies how rigorous population-based studies can translate into actionable insights, making him an essential figure in the fight against China’s growing cancer burden.

Research Focus

Key Achievements

1
H-Index
1
Papers
187
Total Citations
187
Avg Citations/Paper
🏆 Most Cited Paper
Urologic cancer in China
187 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Peking Union Medical College Hospital

Top Papers

  1. 1
    Urologic cancer in China
    187 citations · 2016

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago